Why Inspire V Is Experiencing Slower-Than-Expected Adoption
Inspire CEO Timothy P. Herbert detailed the challenges Inspire V is facing in the US marketplace.
Read MoreInspire CEO Timothy P. Herbert detailed the challenges Inspire V is facing in the US marketplace.
Read MoreIt alleges there were over 44,000 separate instances of unlawful supply of devices.
Read MoreBecause they are both frequent and treatable, the new findings elevate bad dreams from a spooky nuisance to a potential public health target.
Read MoreData from Nyxoah SA’s DREAM pivotal study has been published online in a peer-reviewed journal, revealing 12-month safety and efficacy results for the company’s CE-marked Genio bilateral hypoglossal nerve stimulator.
Read MoreUnderstanding the anatomy involved opens the door to effective, noninvasive solutions.
Read More